Details for New Drug Application (NDA): 011145
✉ Email this page to a colleague
NDA 011145 describes DIURIL, which is a drug marketed by Rising and Salix Pharms and is included in two NDAs. It is available from one supplier. Additional details are available on the DIURIL profile page.
The generic ingredient in DIURIL is chlorothiazide. There are forty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorothiazide profile page.
The generic ingredient in DIURIL is chlorothiazide. There are forty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorothiazide profile page.
Summary for 011145
| Tradename: | DIURIL |
| Applicant: | Rising |
| Ingredient: | chlorothiazide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011145
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
